PlainRecalls
FDA Drug Moderate Class II Completed

Levoxyl (levothyroxine sodium) tablets, USP 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles ( NDC 60793-853-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Reported: April 24, 2013 Initiated: March 28, 2013 #D-254-2013

Product Description

Levoxyl (levothyroxine sodium) tablets, USP 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles ( NDC 60793-853-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.

Reason for Recall

Chemical contamination: emission of strong odor after package was opened..

Details

Recalling Firm
Pfizer Inc.
Units Affected
26447 bottles
Distribution
Nationwide and PR
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Levoxyl (levothyroxine sodium) tablets, USP 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles ( NDC 60793-853-10 ) Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620.. Recalled by Pfizer Inc.. Units affected: 26447 bottles.
Why was this product recalled?
Chemical contamination: emission of strong odor after package was opened..
Which agency issued this recall?
This recall was issued by the FDA Drug on April 24, 2013. Severity: Moderate. Recall number: D-254-2013.